UPDATE Friday, Jan. 28, 2022—This story was updated to include comments by Pharmaceutical Research and Manufacturers of America (PhRMA.)
340B hospitals “are losing significant resources” due to drug companies’ conditions on 340B pricing when covered entities use contract pharmacies, according
…
The American Hospital Association (AHA) yesterday asked U.S. House and Senate party leaders to ensure that a must-pass spending bill next month protects hospitals from losing their 340B eligibility due to changes in patient and payer mix caused by the
…
The National Association of Community Health Centers said in an email to its contacts yesterday that Tom Van Coverden, 74, hired by NACHC in 1975 and its leader for decades, has taken leave and been replaced by an interim president
…
The 340B Coalition, citing the ongoing COVID-19 pandemic, decided Tuesday to give registrants for its upcoming Jan. 31 to Feb. 2 winter conference in San Diego, Calif., the option of attending in person or remotely via an online portal.
Apexus,
…
More than half (52%) of the $81 billion that U.S. pharmacies and health care providers collected in 2020 in reimbursement from payers for brand-name prescription drugs came through pharmacy and provider participation in the 340B program, up from 14% of
…
The 340B Coalition said yesterday it is “actively exploring the potential for a hybrid [winter 2022] conference that would allow attendance in-person or virtually for those that cannot attend in-person.”
The coalition, composed of 13 groups that represent 340B covered
…
Just over 850 hospitals in the 340B program asked the federal government yesterday to appeal a judge’s Nov. 5 ruling that halted enforcement actions against two drug companies that deny 340B pricing when hospitals and others use contract pharmacies. They
…
Groups representing 340B health centers, Ryan White clinics, and hospitals panned drug manufacturer Lilly’s recent decision to amend its prohibition on 340B pricing when providers use contract pharmacies to dispense drugs to patients.
Lilly told drug wholesaler AmerisourceBergen on
…
HIV care professionals are warning the public that threats to 340B drug discount savings “will compromise access to affordable care, treatment, and prevention services for underserved people with and at risk for HIV.”
The American Academy of HIV Medicine, the
…
×
*Sign up for news summaries and alerts from 340B Report